231.19
5.05%
+11.12
Madrigal Pharmaceuticals Inc (MDGL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
18.92%
117.18
|
98.53 | 86.45 | 78.34 | 85.30 |
Interest Income/Expense |
13.33%
3.971
|
3.504 | 2.901 | 2.336 | 1.682 |
Operating Income/Loss |
18.92%
-117.18
|
-98.53 | -86.45 | -78.34 | -85.30 |
Income/Loss From Continuing Operations Before Tax |
13.63%
-112.19
|
-98.74 | -85.80 | -76.90 | -85.91 |
Income/Loss From Continuing Operations After Tax |
13.63%
-112.19
|
-98.74 | -85.80 | -76.90 | -85.91 |
Net Income/Loss
|
13.63%
-112.19
|
-98.74 | -85.80 | -76.90 | -85.91 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
6.95%
19.76
|
18.48 | 18.31 | 18.19 | 17.24 |
Diluted Average Shares |
6.95%
19.76
|
18.48 | 18.31 | 18.19 | 17.24 |
Basic Earnings Per Share |
6.37%
-5.68
|
-5.34 | -4.69 | -4.23 | -4.98 |
Diluted Earnings Per Share |
6.37%
-5.68
|
-5.34 | -4.69 | -4.23 | -4.98 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):